Tobacco Smoking Associated With Increased Anastomotic Disruption Following Pancreaticoduodenectomy.


Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
01 2019
Historique:
received: 03 03 2018
revised: 19 06 2018
accepted: 13 07 2018
entrez: 4 12 2018
pubmed: 7 12 2018
medline: 14 11 2019
Statut: ppublish

Résumé

The effect of cigarette smoking on postoperative morbidity following pancreaticoduodenectomy (PD) for cancer is unclear. We hypothesize that smoking is associated with higher morbidity following PD. A retrospective review of patients undergoing PD for cancer from 2010 to 2016 at a single institution was performed. Patients who had never smoked were compared to current or past-smokers with at least 1 pack-year history. Univariate and multivariable analyses were performed. Two hundred fifty-two patients met inclusion criteria. On univariate analysis, there was a significant difference between smokers and never-smokers in age at diagnosis (65.5 versus 68.6 y, P = 0.013) and fistula rate (28.5% versus 16.2%, P = 0.024). Male sex was significantly associated with fistula rate compared with female sex (15.5% versus 7.1%, P = 0.023). Comparing males and females separately, smoking correlated with higher fistula development only in the male cohort (22.5% versus 5.8%, P = 0.016 in men and 7.3% versus 9.1%, P = 1.00 in women). On multivariable analysis, current and past smoking was independently predictive of developing a fistula: odds ratio of 2.038 (P = 0.030). For current and past-smokers, male sex was an independent risk factor for developing a fistula: odds ratio 2.817 (P = 0.022). There were no other significant differences between groups in rates of postoperative complications. Smoking status is independently predictive of postoperative pancreatic fistula following PD for cancer. Among smokers, male sex is an independent risk factor for fistula. Further studies are needed to determine if smoking cessation before surgery decreases this risk, and if so, the optimal duration of cessation.

Sections du résumé

BACKGROUND
The effect of cigarette smoking on postoperative morbidity following pancreaticoduodenectomy (PD) for cancer is unclear. We hypothesize that smoking is associated with higher morbidity following PD.
METHODS
A retrospective review of patients undergoing PD for cancer from 2010 to 2016 at a single institution was performed. Patients who had never smoked were compared to current or past-smokers with at least 1 pack-year history. Univariate and multivariable analyses were performed.
RESULTS
Two hundred fifty-two patients met inclusion criteria. On univariate analysis, there was a significant difference between smokers and never-smokers in age at diagnosis (65.5 versus 68.6 y, P = 0.013) and fistula rate (28.5% versus 16.2%, P = 0.024). Male sex was significantly associated with fistula rate compared with female sex (15.5% versus 7.1%, P = 0.023). Comparing males and females separately, smoking correlated with higher fistula development only in the male cohort (22.5% versus 5.8%, P = 0.016 in men and 7.3% versus 9.1%, P = 1.00 in women). On multivariable analysis, current and past smoking was independently predictive of developing a fistula: odds ratio of 2.038 (P = 0.030). For current and past-smokers, male sex was an independent risk factor for developing a fistula: odds ratio 2.817 (P = 0.022). There were no other significant differences between groups in rates of postoperative complications.
CONCLUSIONS
Smoking status is independently predictive of postoperative pancreatic fistula following PD for cancer. Among smokers, male sex is an independent risk factor for fistula. Further studies are needed to determine if smoking cessation before surgery decreases this risk, and if so, the optimal duration of cessation.

Identifiants

pubmed: 30502248
pii: S0022-4804(18)30528-6
doi: 10.1016/j.jss.2018.07.047
pmc: PMC6346734
mid: NIHMS1001745
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-206

Subventions

Organisme : NCI NIH HHS
ID : T32 CA126607
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

J Surg Oncol. 2015 Nov;112(6):643-9
pubmed: 26388048
J Hepatobiliary Pancreat Sci. 2017 May;24(5):243-251
pubmed: 28196308
Pancreas. 2011 Aug;40(6):931-7
pubmed: 21747317
Circulation. 1999 Mar 23;99(11):1411-5
pubmed: 10086962
Transl Gastroenterol Hepatol. 2017 Dec 12;2:107
pubmed: 29354764
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Surgery. 2010 Jul;148(1):15-23
pubmed: 20138325
World J Surg. 2011 Dec;35(12):2747-55
pubmed: 21913138
Arch Surg. 2004 Jul;139(7):718-25; discussion 725-7
pubmed: 15249403
Int J Colorectal Dis. 2007 Aug;22(8):919-27
pubmed: 17260142
J Hepatobiliary Pancreat Surg. 2007;14(6):557-63
pubmed: 18040620
HPB (Oxford). 2014 Jul;16(7):620-8
pubmed: 24246089
Am J Surg. 2014 Apr;207(4):540-8
pubmed: 24560585
Microsurgery. 1993;14(6):391-7
pubmed: 8371687
Eur J Cancer. 2014 Mar;50(5):997-1003
pubmed: 24461200
JOP. 2013 Nov 10;14(6):626-31
pubmed: 24216548
Am Surg. 2004 Aug;70(8):675-82; discussion 682-3
pubmed: 15328799
J Cardiovasc Risk. 1999 Oct;6(5):333-6
pubmed: 10534138
Surgery. 2007 Nov;142(5):761-8
pubmed: 17981197
Int J Surg Oncol. 2012;2012:602478
pubmed: 22611494
J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):601-8
pubmed: 21491103
HPB (Oxford). 2010 Dec;12(10):696-702
pubmed: 21083795
Surgery. 2005 Jul;138(1):8-13
pubmed: 16003309
MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1205-1211
pubmed: 27832052
J Gastrointest Surg. 2006 Nov;10(9):1199-210; discussion 1210-1
pubmed: 17114007
Gut. 1996 May;38(5):714-8
pubmed: 8707117
Ann Surg. 2006 Dec;244(6):931-7; discussion 937-9
pubmed: 17122618
J Gastrointest Surg. 2004 Dec;8(8):951-9
pubmed: 15585382
Dig Surg. 2014;31(3):177-84
pubmed: 25097014
J Am Coll Surg. 2015 Apr;220(4):530-6
pubmed: 25724606
Surgery. 2013 May;153(5):641-50
pubmed: 23276391
Arq Gastroenterol. 2014 Jan-Mar;51(1):29-33
pubmed: 24760061
J Am Coll Surg. 2007 Apr;204(4):588-96
pubmed: 17382217
Br J Surg. 1999 Jul;86(7):927-31
pubmed: 10417567
World J Gastroenterol. 2016 Sep 14;22(34):7797-805
pubmed: 27678363
World J Surg. 2013 Jun;37(6):1405-18
pubmed: 23494109
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131

Auteurs

Noah S Rozich (NS)

Department of Surgery, University of Oklahoma Medical Center, Oklahoma City, Oklahoma. Electronic address: noah-rozich@ouhsc.edu.

Alessandra Landmann (A)

Department of Surgery, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.

Casey S Butler (CS)

Department of Surgery, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.

Morgan M Bonds (MM)

Department of Surgery, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.

Laura E Fischer (LE)

Department of Surgery, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.

Russell G Postier (RG)

Department of Surgery, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.

Katherine T Morris (KT)

Department of Surgery, University of Oklahoma Medical Center, Oklahoma City, Oklahoma.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH